Most Popular in:
Oncology Esthetics: Breast Cancer Awareness
By: Morag Currin
Posted: October 2, 2013, from the October 2013 issue of Skin Inc. magazine.
page 3 of 8
Despite the fact that its name includes the term “carcinoma,” LCIS is not a true breast cancer. It is an indication that a client is at higher-than-average risk for getting breast cancer at some point in the future.
Signs and symptoms. LCIS usually does not cause any signs or symptoms, such as a lump or other visible changes to the breast.
Invasive ductal carcinoma (IDC). This is the most common type of breast cancer. IDC starts in a milk duct of the breast, breaks through the wall of the duct and grows into the fatty tissue of the breast. If it gets to this fatty tissue, it may metastasize to other parts of the body through the lymphatic system and bloodstream.
Signs and symptoms. Sometimes, the first sign of IDC is a new lump or mass in the breast that can be felt. (See Signs and Symptoms of IDC and ILC.)
Invasive lobular carcinoma (ILC). This second most common type of invasive breast cancer starts in the milk-producing lobules. Like IDC, it can metastasize to other parts of the body. Some research has suggested that the use of hormone replacement therapy during and after menopause can increase the risk of ILC.
- Oncology Esthetics: A Practitioner's Guide REVISED AND EXPANDED EDITION
- **PRE-ORDER at Amazon.com
Color Images! New chapters on breast cancer, ethnic skin, an updated/expanded drug guide of common and new drugs and much more. This book was written just for you in an organized, no-nonsense way to help you understand the different cancers, the therapies and sensitivities.
Oncology Esthetics Revised and Expanded Edition has been written with heartfelt sensitivity in order to give you the information you need to treat clients who are cancer survivors or are undergoing treatment for cancer.